Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): A UK multicentre, open-label, randomised controlled trial

The Lancet

Volumn 386, Issue 10012, 2015, Pages 2489-2498

  Coates, Laura C ^a,b   Moverley, Anna R ^a,b   McParland, Lucy ^a   Brown, Sarah ^a   Navarro Coy, Nuria ^a   O'Dwyer, John L ^a   Meads, David M ^a   Emery, Paul ^a,b   Conaghan, Philip G ^a,b   Helliwell, Philip S ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b CHAPEL ALLERTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; LEFLUNOMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE; STEROID; ANTIRHEUMATIC AGENT;

ADULT; ARTHRITIS; ARTICLE; AUTOMATION; CLINICAL ASSESSMENT; COMMON COLD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DACTYLITIS; DISEASE ACTIVITY; DISEASE CONTROL; DISEASE DURATION; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; ENTHESITIS; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFLAMMATION; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIGRAINE; MONOTHERAPY; MULTICENTER STUDY; MUSCULOSKELETAL PAIN; NAUSEA; OPEN STUDY; PATIENT CARE; POLYARTHRITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RANDOMIZED CONTROLLED TRIAL; SECONDARY HEALTH CARE; STEROID THERAPY; TELEPHONE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED KINGDOM; ARTHRITIS, PSORIATIC; CLINICAL TRIAL; DRUG COMBINATION; ECONOMICS; STATISTICAL MODEL;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; DRUG THERAPY, COMBINATION; FEMALE; GREAT BRITAIN; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84955557480     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00347-5     Document Type: Article

References (36)

1. K Reich, K Kruger, R Mossner, M Augustin Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis Br J Dermatol 160 2009 1040 1047
2. DD Gladman, C Antoni, P Mease, DO Clegg, P Nash Psoriatic arthritis: epidemiology, clinical features, course, and outcome Ann Rheum Dis 64 suppl 2 2005 ii14 ii17
3. KB Sokoll, PS Helliwell Comparison of disability and quality of life in rheumatoid and psoriatic arthritis J Rheumatol 28 2001 1842 1846
4. DD Gladman, VT Farewell Progression in psoriatic arthritis: role of time varying clinical indicators J Rheumatol 26 1999 2409 2413
5. SJ Bond, VT Farewell, CT Schentag, DD Gladman Predictors for radiological damage in psoriatic arthritis: results from a single centre Ann Rheum Dis 66 2007 370 376
6. C Grigor, H Capell, A Stirling et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial Lancet 364 2004 263 269
7. National Institute for Health and Care Excellence Rheumatoid arthritis: the management of rheumatoid arthritis in adults [CG79] 2009 National Institute for Health and Care Excellence London http://www.nice.org.uk/Guidance/CG79 (accessed Aug 10, 2015).
8. LC Coates, J Fransen, PS Helliwell Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment Ann Rheum Dis 69 2010 48 53
9. LC Coates, PS Helliwell Validation of minimal disease activity (MDA) criteria for psoriatic arthritis using interventional trial data Arthritis Care Res 62 2010 965 969
10. LC Coates, PS Helliwell Comment on: Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register Rheumatology 49 2010 1793 1794
11. V Chandran, CT Schentag, DD Gladman Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: results from a longitudinal observational cohort J Rheumatol 35 2008 469 471
12. M Haroon, P Gallagher, O Fitzgerald Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis Ann Rheum Dis 2014 10.1136/annrheumdis-2013-204858 published 10.1136/annrheumdis-2013-204858
13. LC Coates, N Navarro-Coy, SR Brown et al. The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis BMC Musculoskelet Disord 14 2013 101
14. D Van der Heijde How to read radiographs according to the Sharp/van der Heijde method J Rheumatol 27 2000 261 264
15. T Fredricksson, U Pettersson Severe psoriasis - oral therapy with a new retinoid Dermatologica 157 1978 238 244
16. DD Gladman, PJ Mease, G Krueger et al. Outcome measures in psoriatic arthritis J Rheumatol 32 2005 2262 2269
17. SE Cassell, JD Bieber, P Rich et al. The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis J Rheumatol 34 2007 123 129
18. L Heuft-Dorenbosch, A Spoorenberg, A van Tubergen et al. Assessment of enthesitis in ankylosing spondylitis Ann Rheum Dis 62 2003 127 132
19. P Healy, PS Helliwell Measuring clinical enthesitis in psoriatic arthritis:assessment of existing measures and development of an instrument specific for psoriatic arthritis Arthritis Care Res 59 2008 686 691
20. PJ Healy, PS Helliwell Measuring dactylitis in clinical trials: which is the best instrument to use? J Rheumatol 34 2007 1302 1306
21. A Calin, S Garrett, H Whitelock et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index J Rheumatol 21 1994 2281 2285
22. S Garrett, T Jenkinson, LG Kennedy, H Whitelock, P Gaisford, A Calin A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index J Rheumatol 21 1994 2286 2291
23. SP McKenna, LC Doward, D Whalley, A Tennant, P Emery, DJ Veale Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis Ann Rheum Dis 63 2004 162 169
24. I White, I Roystan, A Wood Multiple imputation using chained equations: issues and guidance for practice Stat Med 30 2011 377 399
25. D Rubin Inference and missing data Biometrika 63 1976 581 590
26. E Fenwick, B O'Brien, A Briggs Cost-effectiveness, acceptability curves, facts, fallacies and frequently asked questions Health Econ 13 2004 405 415
27. S Pavy, S Brophy, A Calin Establishment of the minimum clinically important difference for the bath ankylosing spondylitis indices: a prospective study J Rheumatol 32 2005 80 85
28. MM Schoels, J Braun, M Dougados et al. Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis Ann Rheum Dis 73 2014 238 242
29. AW Armstrong, AD Robertson, J Wu, C Schupp, MG Lebwohl Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the united states: findings from the National Psoriasis Foundation surveys, 2003-2011 JAMA Dermatol 149 2013 1180 1185
30. D Solomon, A Bitton, J Katz, H Radner, Brown, L Fraenkel Treat to target in rheumatoid arthritis Arthritis Rheum 66 2014 775 782
31. L Gossec, JS Smolen, C Gaujoux-Viala et al. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies Ann Rheum Dis 71 2012 4 12
32. GH Kingsley, A Kowalczyk, H Taylor et al. A randomized placebo-controlled trial of methotrexate in psoriatic arthritis Rheumatology 51 2012 1368 1377
33. V Chandran, CT Schentag, DD Gladman Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: results from a longitudinal observational cohort J Rheumatol 35 2008 469 471
34. D Kane, L Stafford, B Bresnihan, O Fitzgerald A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience Rheumatology 42 2003 1460 1468
35. PS Helliwell, O FitzGerald, J Fransen et al. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project) Ann Rheum Dis 72 2013 986 991
36. PS Helliwell, A Kavanaugh Comparison of composite measures of disease activity in psoriatic arthritis using data from an interventional study with golimumab Arthritis Care Res 66 2014 749 756